INDIA – PhableCare, a Bangalore, India-based chronic disease management company, raised USD25M in Series B funding.
The round was led by Kalaari Capital with participation from Aflac Ventures, Digital Horizon, Stride Ventures, Omron Ventures, SOSV, Social Starts, and Fresco Capital.The company intends to use the funds to further strengthen its full-stack and value-driven chronic care ecosystem and accelerate its market expansion, customer acquisition (doctors and patients), brand building, and building new revenue streams.Led by Co-Founders Sumit Sinha and Mukesh Bansal, PhableCare is an app-based and specialized platform for chronic disease care. It connects doctors and patients through a full-stack solution that delivers remote consultations and care, timely and intelligent insights, and simplified access to healthcare essentials. It has built an ecosystem of care providers, hospitals, medical device manufacturers, health & wellness product manufacturers, e-Pharmacy retailers, and insurance partners bringing digital healthcare to millions of Indians. Currently 3 Million+ patients and 10k+ doctors and over 1000+ pharmacists use PhableCare’s technology. 12/04/2022
